Enanta Pharmaceuticals | ENTA - Market Capitalization


Enanta Pharmaceuticals reported $297.2M in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 364.22B 20.46B May/2026
Amgen USD 189.89B 13.64B Mar/2026
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 9.7B 920M May/2026
AstraZeneca USD 301.25B 13.1B Mar/2026
BioCryst Pharmaceuticals USD 1.66B 64M Dec/2025
Biogen USD 26.9B 1.09B Mar/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Enanta Pharmaceuticals USD 122M 98M Dec/2024
Gilead Sciences USD 167.39B 5.6B May/2026
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
Halozyme Therapeutics USD 8.56B 905M May/2026
Heron Therapeutics USD 238M 7M Dec/2025
Immunic USD 64M 23M Dec/2025
Incyte USD 21.73B 3B May/2026
Insmed USD 15.56B 19.73B May/2026
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
J&J USD 579.15B 78.91B Mar/2026
Karyopharm Therapeutics USD 956M 821M May/2026
Ligand Pharmaceuticals USD 3.72B 257M May/2026
Merck USD 297.1B 35.84B Mar/2026
Neurocrine Biosciences USD 15.15B 1.9B May/2026
Novartis USD 232.75B 75B May/2026
Novavax USD 1.09B 316M Dec/2025
Pfizer USD 147.4B 6.42B May/2026
PTC Therapeutics USD 4.94B 698M May/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sarepta Therapeutics USD 2.16B 123M May/2026
Vertex Pharmaceuticals USD 113.58B 1000K May/2026